{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:20:50Z","timestamp":1762251650955},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ncl.2010.03.001","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T09:28:17Z","timestamp":1279272497000},"page":"573-580","source":"Crossref","is-referenced-by-count":6,"title":["Optic Neuritis"],"prefix":"10.1016","volume":"28","author":[{"given":"David","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Workayehu","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Eggenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2010.03.001_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of acute optic neuritis: experience of the optic neuritis treatment trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.001_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic Neuritis, a population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.001_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041327-199503000-00002","article-title":"Pain in anterior ischemic optic neuropathy","volume":"15","author":"Swartz","year":"1995","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.001_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.46.2.368","article-title":"Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial","volume":"46","author":"Rolak","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.001_bib5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. Optic Neuritis Study Group","volume":"49","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.001_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Optic Neuritis Study Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.001_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archneur.65.6.727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2010.03.001_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S031716710000915X","article-title":"Retinal nerve fiber layer and future risk of multiple sclerosis","volume":"35","author":"Costello","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ncl.2010.03.001_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2010.03.001_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","article-title":"Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis","volume":"72","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.001_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A\u00a0randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.001_bib12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.001_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(01)01209-0","article-title":"Interferon \u03b2-1a for optic neuritis patients at high risk for multiple sclerosis","volume":"132","author":"CHAMPS Study Group","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.001_bib14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. (CHAMPS Study Group)","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2010.03.001_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.001_bib16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomized, double-blinded, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T13:55:32Z","timestamp":1544363732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861910000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0733861910000393"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2010.03.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}